In diabetic nephropathies, SCX also activates the expression of α-SMA/ACTA2 and bone morphogenetic protein 4, to promote differentiation of mesangial cells into activated myofibroblasts [40]. This evidence concerns the gene SCX and diabetic kidney disease.